1. Home
  2. BCDA vs XELB Comparison

BCDA vs XELB Comparison

Compare BCDA & XELB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$0.97

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

HOLD

Current Price

$2.00

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
XELB
Founded
N/A
2011
Country
United States
United States
Employees
21
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
10.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
BCDA
XELB
Price
$0.97
$2.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$25.00
$3.00
AVG Volume (30 Days)
6.5M
119.3K
Earning Date
05-13-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.37
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$102.11
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$0.74
52 Week High
$2.45
$2.66

Technical Indicators

Market Signals
Indicator
BCDA
XELB
Relative Strength Index (RSI) 51.26 48.28
Support Level $0.81 $1.23
Resistance Level $1.36 $2.33
Average True Range (ATR) 0.14 0.22
MACD 0.02 -0.00
Stochastic Oscillator 17.74 53.47

Price Performance

Historical Comparison
BCDA
XELB

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

Share on Social Networks: